Source link : https://www.newshealth.biz/health-news/fda-oks-voquezna-for-heartburn-relief-in-nonerosive-gerd/
The US Food and Drug Administration (FDA) approved Voquezna (vonoprazan, Phathom Pharmaceuticals) 10-mg tablets for the relief of heartburn associated with nonerosive gastroesophageal reflux disease (GERD) in adults. It represents the third indication for the potassium-competitive acid blocker, which is already approved to treat all severities of erosive esophagitis and to eradicate Helicobacter pylori infection […]
Author : News Health
Publish date : 2024-07-18 19:21:47
Copyright for syndicated content belongs to the linked Source.